Pretax income is the income that a company earns before paying income taxes. Fortrea Holdings's pretax income for the
three
months ended in Mar. 2024 was $-78 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was $-98 Mil.
Fortrea Holdings's pretax margin was -11.71%.
During the past 4 years, Fortrea Holdings's highest Pretax Margin was 7.65%. The lowest was -12.87%. And the median was 2.25%.
Fortrea Holdings Pre-Tax Income Historical Data
The historical data trend for Fortrea Holdings's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Fortrea Holdings's Pre-Tax Income
For the Biotechnology subindustry, Fortrea Holdings's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fortrea Holdings's Pre-Tax Income Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Fortrea Holdings's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Fortrea Holdings's Pre-Tax Income falls into.
Fortrea Holdings Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Fortrea Holdings's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-98 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fortrea Holdings (NAS:FTRE) Pre-Tax Income Explanation
Fortrea Holdings's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as
During the past 4 years, Fortrea Holdings's highest Pretax Margin was 7.65%. The lowest was -12.87%. And the median was 2.25%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fortrea Holdings Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Fortrea Holdings's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Fortrea Holdings (Fortrea Holdings) Business Description
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after LabCorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FTRE has been successfully added to your 